187 related articles for article (PubMed ID: 24121235)
1. Platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane derivatives as carrier ligands and 3-hydroxycyclobutane-1,1-dicarboxylate as a leaving group: potent cytotoxicity and DNA binding ability.
Fang L; Gou S; Zhao J; Sun Y; Cheng L
Eur J Med Chem; 2013 Nov; 69():842-7. PubMed ID: 24121235
[TBL] [Abstract][Full Text] [Related]
2. Antitumor platinum(II) complexes of N-monoalkyl-1R, 2R-diaminocyclohexane derivatives with alkyl groups as hindrance.
Sun Y; Yin R; Gou S; Zhaojian
J Inorg Biochem; 2012 Jul; 112():68-76. PubMed ID: 22561544
[TBL] [Abstract][Full Text] [Related]
3. Novel oxaliplatin derivatives with 1-(substituted benzyl)azetidine-3,3-dicarboxylate anions. Synthesis, cytotoxicity, and interaction with DNA.
Sun Y; Cao Z; Gou S; Hu T
Chem Biodivers; 2014 Jan; 11(1):115-25. PubMed ID: 24443431
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro cytotoxicity, and interaction with DNA of platinum(II) complexes with N-monocycloalkyl derivatives of 1R,2R-diaminocyclohexane as carrier ligands.
Sun Y; Gou S; Liu F; Yin R; Fang L
ChemMedChem; 2012 Apr; 7(4):642-9. PubMed ID: 22247027
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands.
Sun Y; Liu F; Gou S; Cheng L; Fang L; Yin R
Eur J Med Chem; 2012 Sep; 55():297-306. PubMed ID: 22867527
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity profile of novel sterically hindered platinum(II) complexes with (1R,2R)-N(1),N(2)-dibutyl-1,2-diaminocyclohexane.
Zhang H; Gou S; Zhao J; Chen F; Xu G; Liu X
Eur J Med Chem; 2015; 96():187-95. PubMed ID: 25874342
[TBL] [Abstract][Full Text] [Related]
7. Antitumor platinum(II) complexes of N-monoalkyl 1R,2R-diamino-cyclohexanes with 3-(nitrooxy)cyclobutane-1,1-dicarboxylate as a leaving group.
Zhao J; Gou S; Xu G; Cheng L
Eur J Med Chem; 2014 Oct; 85():408-17. PubMed ID: 25108080
[TBL] [Abstract][Full Text] [Related]
8. Antitumor platinum(II) complexes of N-cyclobutyl-1R,2R-diaminocyclohexane with dicarboxylates as leaving groups.
Xu G; Zhao J; Gou S; Pang J
Bioorg Med Chem Lett; 2015 Jan; 25(2):221-4. PubMed ID: 25499430
[TBL] [Abstract][Full Text] [Related]
9. Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.
Zhou Z; Chen F; Xu G; Gou S
Bioorg Med Chem Lett; 2016 Jan; 26(2):322-327. PubMed ID: 26711148
[TBL] [Abstract][Full Text] [Related]
10. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
11. In vitro biological evaluation of platinum(II) complexes with 1-(methoxy substituted benzyl) azetidine-3,3-dicarboxylato ligands.
Yin R; Gou S; Sun Y; Liu X
Bioorg Med Chem; 2012 Feb; 20(4):1461-7. PubMed ID: 22264764
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antiproliferative activity and DNA binding study of mixed ammine/cyclohexylamine platinum(II) complexes with 1-(substituted benzyl) azetidine-3, 3-dicarboxylates.
Sun Y; Gou S; Yin R; Jiang P
Eur J Med Chem; 2011 Oct; 46(10):5146-53. PubMed ID: 21875765
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, cytotoxicity, induction of apoptosis, and interaction with DNA of dinuclear platinum(II) complexes.
Xu G; Gao C; Gou S; Cao Z
ChemMedChem; 2012 Nov; 7(11):2004-9. PubMed ID: 23015351
[TBL] [Abstract][Full Text] [Related]
14. Potent anticancer activity and possible low toxicity of platinum(II) complexes with functionalized 1,1-cyclobutanedicarboxylate as a leaving ligand.
Zhao J; Gou S; Liu F
Chemistry; 2014 Nov; 20(46):15216-25. PubMed ID: 25256173
[TBL] [Abstract][Full Text] [Related]
15. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activities and interaction with DNA of oxaliplatin-type platinum complexes with linear or branched alkoxyacetates as leaving groups.
Yin R; Gou S; Liu X; Lou L
J Inorg Biochem; 2011 Aug; 105(8):1095-101. PubMed ID: 21726773
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological studies of pyrazolyl-diamine Pt(II) complexes containing polyaromatic DNA-binding groups.
Gama S; Mendes F; Esteves T; Marques F; Matos A; Rino J; Coimbra J; Ravera M; Gabano E; Santos I; Paulo A
Chembiochem; 2012 Nov; 13(16):2352-62. PubMed ID: 23038670
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Biological Features of Platinum(II) Complexes with Rigid Steric Hindrance.
Wang Z; Yu H; Gou S; Chen F; Fang L
Inorg Chem; 2016 May; 55(9):4519-28. PubMed ID: 27074104
[TBL] [Abstract][Full Text] [Related]
19. cis-[Pt(II) (1R,2R-DACH)(3-acetoxy-1,1-cyclobutanedicarboxylato)], a water-soluble, oxalate-free and stable analogue of oxaliplatin: synthesis, characterization, and biological evaluations.
Liu W; Ye Q; Jiang J; Lou L; Xu Y; Xie C; Xie M
ChemMedChem; 2013 Sep; 8(9):1465-7. PubMed ID: 23825063
[No Abstract] [Full Text] [Related]
20. Cytotoxicity and DNA interactions of some platinum(II) complexes with substituted benzimidazole ligands.
Ozçelik AB; Utku S; Gümüş F; Keskin AÇ; Açık L; Yılmaz S; Ozgüngör A
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):413-8. PubMed ID: 22299582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
